Karyopharm Therapeutics Ownership 2024 | Who Owns Karyopharm Therapeutics Now?
Institutional Ownership
22.15%
Insider Ownership
6.07%
Retail Ownership
71.78%
Institutional Holders
57.00
Karyopharm Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 6.63% | 0.00% | 7,654,482 | -683,919 | -8.20% | 6,641,029 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 4.42% | 0.51% | 5,102,193 | - | - | 4,426,663 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 4.32% | 0.30% | 4,987,180 | -29,140 | -0.58% | 4,326,877 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.74% | 0.01% | 4,319,842 | 819,842 | 23.42% | 3,747,895 | Jun 30, 2024 |
| BLACKROCK INC. | 3.61% | 0.00% | 4,169,788 | -5,277,890 | -55.86% | 3,617,707 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.24% | 0.00% | 2,580,863 | -14,736 | -0.57% | 2,245,351 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.98% | 0.00% | 2,290,434 | 782,172 | 51.86% | 1,987,181 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 1.97% | 0.00% | 2,274,195 | 500,437 | 28.21% | 1,973,092 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.81% | 0.00% | 2,092,426 | 906,547 | 76.45% | 1,815,389 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.75% | 0.07% | 2,018,500 | -6,280,070 | -75.68% | 1,751,251 | Jun 30, 2024 |
| C WORLDWIDE GROUP HOLDING A/S | 1.30% | 0.01% | 1,500,000 | - | - | 1,301,000 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.23% | 0.28% | 1,425,000 | 1,425,000 | 100.00% | 1,236,330 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.14% | 0.00% | 1,311,536 | -1,208,569 | -47.96% | 1,138,154 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.11% | 0.00% | 1,275,859 | -101,725 | -7.38% | 1,106,935 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.10% | 0.00% | 1,268,777 | -56,200 | -4.24% | 1,103,836 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.04% | 0.02% | 1,196,792 | 1,196,792 | 100.00% | 1,038,337 | Jun 30, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.97% | 0.72% | 1,125,000 | - | - | 976,050 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.95% | 0.06% | 1,102,391 | 380,064 | 52.62% | 956,875 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.85% | 0.06% | 983,417 | -315,734 | -24.30% | 853,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.76% | 0.00% | 873,274 | -19,541 | -2.19% | 758,000 | Jun 30, 2024 |
Karyopharm Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 6.63% of the company's total share outstanding, currently valued at $6.64M. The top 10 institutional shareholders own together 32.47% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALPHACENTRIC ADVISORS LLC | 0.97% | 0.72% | 1,125,000 | - | - | 976,050 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.46% | 0.58% | 534,485 | 534,485 | 100.00% | 463,719 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 4.42% | 0.51% | 5,102,193 | - | - | 4,426,663 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.41% | 0.38% | 469,832 | - | - | 407,626 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 4.32% | 0.30% | 4,987,180 | -29,140 | -0.58% | 4,326,877 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.23% | 0.28% | 1,425,000 | 1,425,000 | 100.00% | 1,236,330 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.64% | 0.26% | 740,000 | - | - | 642,024 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.48% | 0.11% | 558,466 | - | - | 484,525 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.75% | 0.07% | 2,018,500 | -6,280,070 | -75.68% | 1,751,251 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.35% | 0.06% | 409,355 | - | - | 355,157 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.85% | 0.06% | 983,417 | -315,734 | -24.30% | 853,000 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.95% | 0.06% | 1,102,391 | 380,064 | 52.62% | 956,875 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.17% | 0.04% | 192,678 | - | - | 167,167 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.14% | 0.03% | 165,318 | 165,318 | 100.00% | 143,430 | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.23% | 0.02% | 261,847 | 17,450 | 7.14% | 227,179 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.03% | 0.02% | 34,030 | 34,030 | 100.00% | 29,524 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.04% | 0.02% | 1,196,792 | 1,196,792 | 100.00% | 1,038,337 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.36% | 0.02% | 410,954 | 410,954 | 100.00% | 356,544 | Jun 30, 2024 |
| KENNEDY INVESTMENT GROUP | 0.03% | 0.02% | 35,000 | - | - | 30,366 | Jun 30, 2024 |
| C WORLDWIDE GROUP HOLDING A/S | 1.30% | 0.01% | 1,500,000 | - | - | 1,301,000 | Jun 30, 2024 |
The largest Karyopharm Therapeutics shareholder by % of total assets is ALPHACENTRIC ADVISORS LLC. The company owns 1.13M shares of Karyopharm Therapeutics (KPTI), representing 0.72% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 1.23% | 0.28% | 1,425,000 | 1,425,000 | 100.00% | 1,236,330 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.04% | 0.02% | 1,196,792 | 1,196,792 | 100.00% | 1,038,337 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.81% | 0.00% | 2,092,426 | 906,547 | 76.45% | 1,815,389 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.74% | 0.01% | 4,319,842 | 819,842 | 23.42% | 3,747,895 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.98% | 0.00% | 2,290,434 | 782,172 | 51.86% | 1,987,181 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.65% | 0.00% | 748,020 | 622,194 | 494.49% | 648,982 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.49% | 0.00% | 568,975 | 568,975 | 100.00% | 493,643 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.46% | 0.58% | 534,485 | 534,485 | 100.00% | 463,719 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 1.97% | 0.00% | 2,274,195 | 500,437 | 28.21% | 1,973,092 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.36% | 0.02% | 410,954 | 410,954 | 100.00% | 356,544 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.95% | 0.06% | 1,102,391 | 380,064 | 52.62% | 956,875 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.18% | 0.00% | 203,600 | 203,600 | 100.00% | 176,643 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.17% | 0.00% | 194,168 | 194,168 | 100.00% | 167,000 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.14% | 0.03% | 165,318 | 165,318 | 100.00% | 143,430 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.13% | 0.00% | 147,536 | 147,536 | 100.00% | 128,000 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.13% | 0.00% | 144,508 | 144,508 | 100.00% | 125,375 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.26% | - | 298,685 | 140,770 | 89.14% | 258,960 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.09% | 0.00% | 106,470 | 106,470 | 100.00% | 92,374 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.23% | 0.01% | 264,500 | 75,000 | 39.58% | 229,480 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.06% | 0.00% | 68,932 | 68,932 | 100.00% | 59,805 | Jun 30, 2024 |
As of Jun 30 2024, Karyopharm Therapeutics's largest institutional buyer is OPALEYE MANAGEMENT INC.. The company purchased 1.43M stocks of KPTI, valued at $1.24M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | 1.75% | 0.07% | 2,018,500 | -6,280,070 | -75.68% | 1,751,251 | Jun 30, 2024 |
| BLACKROCK INC. | 3.61% | 0.00% | 4,169,788 | -5,277,890 | -55.86% | 3,617,707 | Jun 30, 2024 |
| STATE STREET CORP | 0.39% | - | 453,810 | -1,831,978 | -80.15% | 393,726,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.14% | 0.00% | 1,311,536 | -1,208,569 | -47.96% | 1,138,154 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.63% | 0.00% | 7,654,482 | -683,919 | -8.20% | 6,641,029 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -492,365 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -325,800 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.14% | - | 166,315 | -320,745 | -65.85% | 144,295 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.85% | 0.06% | 983,417 | -315,734 | -24.30% | 853,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.04% | - | 51,000 | -258,909 | -83.54% | 44,248 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -229,924 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -192,810 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.66% | 0.00% | 756,227 | -150,573 | -16.60% | 656,103 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 16,431 | -127,597 | -88.59% | 14,261 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.73% | 0.00% | 844,112 | -118,713 | -12.33% | 732,351 | Jun 30, 2024 |
| UBS GROUP AG | 0.12% | - | 140,678 | -114,255 | -44.82% | 122,108 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.12% | 0.01% | 140,576 | -102,265 | -42.11% | 121,964 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.11% | 0.00% | 1,275,859 | -101,725 | -7.38% | 1,106,935 | Jun 30, 2024 |
| MORGAN STANLEY | 0.17% | - | 200,008 | -94,779 | -32.15% | 173,527 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.75% | 0.00% | 870,167 | -88,638 | -9.24% | 754,956,000 | Jun 30, 2024 |
As of Jun 30 2024, Karyopharm Therapeutics's biggest institutional seller is AVIDITY PARTNERS MANAGEMENT LP. The company sold -6.28M shares of KPTI, valued at $1.75M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 1.23% | 0.28% | 1,425,000 | 1,425,000 | 100.00% | 1,236,330 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.04% | 0.02% | 1,196,792 | 1,196,792 | 100.00% | 1,038,337 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.46% | 0.58% | 534,485 | 534,485 | 100.00% | 463,719 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.36% | 0.02% | 410,954 | 410,954 | 100.00% | 356,544 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.18% | 0.00% | 203,600 | 203,600 | 100.00% | 176,643 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.14% | 0.03% | 165,318 | 165,318 | 100.00% | 143,430 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.13% | 0.00% | 147,536 | 147,536 | 100.00% | 128,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.09% | 0.00% | 106,470 | 106,470 | 100.00% | 92,374 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.06% | 0.00% | 68,932 | 68,932 | 100.00% | 59,805 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 57,600 | 57,600 | 100.00% | 49,973 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 56,945 | 56,945 | 100.00% | 49,405 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.03% | 0.00% | 35,939 | 35,939 | 100.00% | 31,181 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.02% | 0.00% | 26,798 | 26,798 | 100.00% | 23,250 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.02% | - | 22,562 | 22,562 | 100.00% | 19,575 | Jun 30, 2024 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0.02% | 0.00% | 21,941 | 21,941 | 100.00% | 19,036 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.01% | 0.00% | 15,435 | 15,435 | 100.00% | 13,391 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.01% | - | 13,993 | 13,993 | 100.00% | 12,140 | Jun 30, 2024 |
| BLB&B ADVISORS, LLC | 0.01% | 0.00% | 11,150 | 11,150 | 100.00% | 9,674 | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | 0.01% | 0.00% | 10,950 | 10,950 | 100.00% | 9,500 | Jun 30, 2024 |
| CWM, LLC | 0.01% | - | 6,248 | 6,248 | 100.00% | 5,000 | Jun 30, 2024 |
| QUENT CAPITAL, LLC | 0.00% | 0.00% | 3,489 | 3,489 | 100.00% | 3,027 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 868 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | - | 538 | 538 | 100.00% | 467 | Jun 30, 2024 |
Karyopharm Therapeutics's largest new institutional shareholder by number of shares is OPALEYE MANAGEMENT INC., purchased 1.43M shares, valued at $1.24M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -492,365 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -325,800 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -229,924 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -192,810 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -76,317 | -100.00% | - | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | - | - | - | -60,551 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -55,985 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -55,816 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -38,802 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -37,132 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -35,868 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -33,165 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -27,015 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -23,500 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -19,615 | -100.00% | - | Jun 30, 2024 |
| DIVERSIFIED TRUST CO | - | - | - | -18,580 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -13,735 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -11,387 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -10,208 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -6,231 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -6,194 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -2,478 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -1,479 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -1,242 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -50 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
Karyopharm Therapeutics's largest sold out institutional shareholder by shares sold is NUVEEN ASSET MANAGEMENT, LLC, sold -0.49M shares, valued at -, as of undefined.
Karyopharm Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 7.71% | 27,475 | - | - | Feb 29, 2024 |
| Manager Directed Portfolios | 1.57% | 257,921 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 1.55% | 380,158 | - | - | Dec 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.43% | 500,000 | 120,000 | 31.58% | Mar 28, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.42% | 262,228 | - | - | Feb 29, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.40% | 945,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.35% | 1,710,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.34% | 1,290,000 | - | - | Jan 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.28% | 53,751 | - | - | Mar 28, 2024 |
| Virtus Equity & Convertible Income Fund | 0.28% | 555,000 | - | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.23% | 470,000 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.22% | 4,645,000 | - | - | Mar 28, 2024 |
| M FUND INC | 0.20% | 90,571 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.18% | 2,262,243 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.17% | 90,538 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.15% | 395,613 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.12% | 404,145 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.10% | 334,243 | - | - | Mar 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.08% | 243,417 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 189,500 | -100,000 | -34.54% | Mar 28, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.08% | 65,743 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 355,847 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.06% | 851,182 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.05% | 4,320 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.04% | 90,194 | - | - | Jan 31, 2024 |
| IndexIQ ETF Trust | 0.03% | 77,462 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 196,221 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.03% | 25,566 | - | - | Dec 31, 2023 |
| ETFis Series Trust I | 0.03% | 44,364 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 17,768 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.03% | 169,383 | 57,369 | 51.22% | Aug 31, 2023 |
| BNY Mellon Strategic Funds, Inc. | 0.02% | 46,758 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 59,290 | - | - | Feb 29, 2024 |
| LKCM Funds | 0.02% | 60,000 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 52,293 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 19,398 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 260 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 4,939,544 | -1,406,429 | -22.16% | Mar 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.01% | 698 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,103 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.01% | 9,300 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 167,445 | -1,938 | -1.14% | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.01% | 455,288 | -349,995 | -43.46% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 99,848 | - | - | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.01% | 5,342 | - | - | Sep 30, 2023 |
| SCHWAB CAPITAL TRUST | 0.01% | 309,909 | 51,000 | 19.70% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 27,664 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 37,018 | - | - | Mar 31, 2020 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.01% | 3,658 | 791 | 27.59% | Sep 30, 2020 |
| ALPS ETF Trust | 0.01% | 80,779 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.01% | 136,324 | 21,849 | 19.09% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.01% | 932,848 | - | - | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.01% | 100,000 | - | - | Feb 29, 2024 |
| GPS Funds I | 0.01% | 29,892 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.01% | 213,174 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,077,548 | 150,307 | 16.21% | Feb 29, 2024 |
| HARBOR FUNDS | 0.01% | 115,868 | - | - | Jan 31, 2024 |
| FORUM FUNDS | 0.00% | 10,535 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 133,480 | - | - | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 20,173 | - | - | Mar 28, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 32,963 | - | - | Mar 28, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 82,696 | -5,266 | -5.99% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 160,610 | - | - | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 104,825 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,194 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 74,654 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 21,323 | - | - | Dec 31, 2023 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 223,243 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 628,000 | - | - | Jan 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 81,000 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 38,594 | - | - | Mar 31, 2024 |
| Weiss Strategic Interval Fund | 0.00% | 5,864 | 5,864 | - | Sep 30, 2022 |
| LAZARD FUNDS INC | 0.00% | 70,000 | -37,000 | -34.58% | Mar 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.00% | 56,867 | - | - | Jan 31, 2024 |
| AMG Funds I | 0.00% | 3,171 | - | - | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 253,526 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 33,671 | 1,399 | 4.34% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 17,929 | 412 | 2.35% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 10,409 | - | - | Jan 31, 2024 |
| Destra Investment Trust | 0.00% | 2,266 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 38,802 | -6,669 | -14.67% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 993 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 578 | - | - | Apr 30, 2021 |
| Forethought Variable Insurance Trust | 0.00% | 4,228 | - | - | Mar 28, 2024 |
| SSGA FUNDS | 0.00% | 419 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 4,516 | -2,242 | -33.18% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 90,435 | -19,549 | -17.77% | Feb 29, 2024 |
| GLENMEDE FUND INC | 0.00% | 7,718 | - | - | Jan 31, 2024 |
| North Square Investments Trust | 0.00% | 8,200 | - | - | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 201,569 | - | - | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 2,929 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 41,400 | 11,200 | 37.09% | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 12,336 | - | - | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 291,765 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 15,881 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,306 | - | - | Mar 31, 2024 |
| Virtus Strategy Trust | 0.00% | 9,660 | - | - | Mar 28, 2024 |
| VIRTUS ASSET TRUST | 0.00% | 11,386 | - | - | Mar 28, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 4,190 | - | - | Feb 29, 2024 |
| VALIC Co II | 0.00% | 13,200 | 200 | 1.54% | Feb 28, 2021 |
Karyopharm Therapeutics's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 27.48K shares, compromising 7.71% of its total assets.
Karyopharm Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 57 | -52.50% |
| 31 Mar, 24 | 120 | -3.23% |
| 31 Dec, 23 | 124 | -1.59% |
| 30 Sep, 23 | 126 | -12.50% |
| 30 Jun, 23 | 144 | 5.88% |
| 31 Mar, 23 | 136 | -15.53% |
| 31 Dec, 22 | 161 | 5.92% |
| 30 Sep, 22 | 152 | -1.94% |
| 30 Jun, 22 | 155 | 5.44% |
| 31 Mar, 22 | 147 | -3.29% |
| 31 Dec, 21 | 152 | 7.04% |
| 30 Sep, 21 | 142 | -11.25% |
| 30 Jun, 21 | 160 | -9.09% |
| 31 Mar, 21 | 176 | -1.12% |
| 31 Dec, 20 | 178 | 6.59% |
| 30 Sep, 20 | 167 | 0.60% |
| 30 Jun, 20 | 166 | 9.93% |
| 31 Mar, 20 | 151 | -2.58% |
| 31 Dec, 19 | 155 | 37.17% |
| 30 Sep, 19 | 113 | 0.89% |
| 30 Jun, 19 | 112 | -2.61% |
| 31 Mar, 19 | 115 | -4.17% |
| 31 Dec, 18 | 120 | -4.76% |
| 30 Sep, 18 | 126 | 13.51% |
| 30 Jun, 18 | 111 | 15.63% |
| 31 Mar, 18 | 96 | 5.49% |
| 31 Dec, 17 | 91 | 12.35% |
| 30 Sep, 17 | 81 | -1.22% |
| 30 Jun, 17 | 82 | -5.75% |
| 31 Mar, 17 | 87 | -1.14% |
| 31 Dec, 16 | 88 | 7.32% |
| 30 Sep, 16 | 82 | 2.50% |
| 30 Jun, 16 | 80 | -2.44% |
| 31 Mar, 16 | 82 | -13.68% |
| 31 Dec, 15 | 95 | -4.04% |
| 30 Sep, 15 | 99 | 4.21% |
| 30 Jun, 15 | 95 | 5.56% |
| 31 Mar, 15 | 90 | 7.14% |
| 31 Dec, 14 | 84 | 15.07% |
| 30 Sep, 14 | 73 | -6.41% |
| 30 Jun, 14 | 78 | 30.00% |
| 31 Mar, 14 | 60 | 11.11% |
| 31 Dec, 13 | 54 | - |
As of 30 Jun 24, 57 institutions are holding Karyopharm Therapeutics's shares, representing a decrease of -52.50% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 25,574,412 | -65.80% |
| 31 Mar, 24 | 74,774,768 | 1.78% |
| 31 Dec, 23 | 73,464,527 | -4.85% |
| 30 Sep, 23 | 77,205,610 | -5.32% |
| 30 Jun, 23 | 81,541,549 | -6.87% |
| 31 Mar, 23 | 87,557,557 | -10.26% |
| 31 Dec, 22 | 97,570,382 | 46.34% |
| 30 Sep, 22 | 66,671,715 | -0.67% |
| 30 Jun, 22 | 67,120,164 | -1.71% |
| 31 Mar, 22 | 68,289,213 | 26.18% |
| 31 Dec, 21 | 54,118,861 | -5.47% |
| 30 Sep, 21 | 57,253,148 | -2.80% |
| 30 Jun, 21 | 58,904,876 | -2.06% |
| 31 Mar, 21 | 60,142,200 | -5.76% |
| 31 Dec, 20 | 63,820,587 | -2.00% |
| 30 Sep, 20 | 65,123,005 | -6.62% |
| 30 Jun, 20 | 69,739,080 | 2.55% |
| 31 Mar, 20 | 68,001,776 | 15.36% |
| 31 Dec, 19 | 58,945,053 | 0.81% |
| 30 Sep, 19 | 58,470,021 | 14.23% |
| 30 Jun, 19 | 51,186,747 | -0.11% |
| 31 Mar, 19 | 51,242,705 | -0.33% |
| 31 Dec, 18 | 51,413,229 | 18.72% |
| 30 Sep, 18 | 43,305,988 | -0.11% |
| 30 Jun, 18 | 43,354,460 | 40.34% |
| 31 Mar, 18 | 30,892,143 | -0.37% |
| 31 Dec, 17 | 31,007,685 | 7.88% |
| 30 Sep, 17 | 28,742,383 | 3.46% |
| 30 Jun, 17 | 27,781,253 | 3.48% |
| 31 Mar, 17 | 26,847,139 | 5.42% |
| 31 Dec, 16 | 25,467,502 | 9.86% |
| 30 Sep, 16 | 23,181,403 | 15.65% |
| 30 Jun, 16 | 20,044,979 | -5.30% |
| 31 Mar, 16 | 21,166,905 | -1.66% |
| 31 Dec, 15 | 21,524,797 | -8.80% |
| 30 Sep, 15 | 23,602,094 | 5.10% |
| 30 Jun, 15 | 22,456,409 | 7.99% |
| 31 Mar, 15 | 20,794,260 | 10.95% |
| 31 Dec, 14 | 18,742,490 | 11.44% |
| 30 Sep, 14 | 16,817,975 | 11.25% |
| 30 Jun, 14 | 15,117,626 | 49.76% |
| 31 Mar, 14 | 10,094,534 | 11.03% |
| 31 Dec, 13 | 9,091,630 | - |
Karyopharm Therapeutics (KPTI) has 25.57M shares outstanding as of 30 Jun 24, down -65.80% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 22.15% | 0.52% |
| 31 Mar, 24 | 65.47% | 1.59% |
| 31 Dec, 23 | 64.22% | 1.41% |
| 30 Sep, 23 | 67.60% | 1.31% |
| 30 Jun, 23 | 71.85% | 1.21% |
| 31 Mar, 23 | 77.16% | 0.66% |
| 31 Dec, 22 | 108.49% | 1.57% |
| 30 Sep, 22 | 83.12% | 1.17% |
| 30 Jun, 22 | 84.27% | 1.09% |
| 31 Mar, 22 | 88.04% | 1.70% |
| 31 Dec, 21 | 71.95% | 1.25% |
| 30 Sep, 21 | 75.87% | 1.24% |
| 30 Jun, 21 | 78.34% | 1.20% |
| 31 Mar, 21 | 80.71% | 1.08% |
| 31 Dec, 20 | 86.56% | 1.10% |
| 30 Sep, 20 | 88.64% | 0.98% |
| 30 Jun, 20 | 95.22% | 0.94% |
| 31 Mar, 20 | 100.55% | 1.11% |
| 31 Dec, 19 | 95.14% | 1.07% |
| 30 Sep, 19 | 94.17% | 1.33% |
| 30 Jun, 19 | 84.01% | 1.18% |
| 31 Mar, 19 | 84.20% | 1.03% |
| 31 Dec, 18 | 90.55% | 1.77% |
| 30 Sep, 18 | 71.48% | 1.20% |
| 30 Jun, 18 | 77.30% | 1.99% |
| 31 Mar, 18 | 62.28% | 1.36% |
| 31 Dec, 17 | 67.56% | 1.82% |
| 30 Sep, 17 | 60.97% | 1.66% |
| 30 Jun, 17 | 60.62% | 1.48% |
| 31 Mar, 17 | 64.08% | 1.69% |
| 31 Dec, 16 | 61.55% | 1.55% |
| 30 Sep, 16 | 62.96% | 2.03% |
| 30 Jun, 16 | 55.75% | 1.60% |
| 31 Mar, 16 | 59.00% | 1.62% |
| 31 Dec, 15 | 60.43% | 1.38% |
| 30 Sep, 15 | 66.10% | 1.67% |
| 30 Jun, 15 | 62.91% | 1.81% |
| 31 Mar, 15 | 58.88% | 1.62% |
| 31 Dec, 14 | 60.20% | 2.26% |
| 30 Sep, 14 | 51.65% | 1.99% |
| 30 Jun, 14 | 50.97% | 4.38% |
| 31 Mar, 14 | 34.10% | 3.62% |
| 31 Dec, 13 | 30.71% | - |
As of 30 Jun 24, Karyopharm Therapeutics is held by 22.15% institutional shareholders, representing a 0.52% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 20 | -64.91% |
| 31 Mar, 24 | 57 | 18.75% |
| 31 Dec, 23 | 48 | -14.29% |
| 30 Sep, 23 | 56 | -24.32% |
| 30 Jun, 23 | 74 | - |
| 31 Mar, 23 | 74 | -22.11% |
| 31 Dec, 22 | 95 | 21.79% |
| 30 Sep, 22 | 78 | 11.43% |
| 30 Jun, 22 | 70 | - |
| 31 Mar, 22 | 70 | -9.09% |
| 31 Dec, 21 | 77 | 11.59% |
| 30 Sep, 21 | 69 | -10.39% |
| 30 Jun, 21 | 77 | -7.23% |
| 31 Mar, 21 | 83 | -13.54% |
| 31 Dec, 20 | 96 | 14.29% |
| 30 Sep, 20 | 84 | -21.50% |
| 30 Jun, 20 | 107 | 27.38% |
| 31 Mar, 20 | 84 | -12.50% |
| 31 Dec, 19 | 96 | 47.69% |
| 30 Sep, 19 | 65 | 14.04% |
| 30 Jun, 19 | 57 | -9.52% |
| 31 Mar, 19 | 63 | -3.08% |
| 31 Dec, 18 | 65 | 30.00% |
| 30 Sep, 18 | 50 | -31.51% |
| 30 Jun, 18 | 73 | 40.38% |
| 31 Mar, 18 | 52 | - |
| 31 Dec, 17 | 52 | 18.18% |
| 30 Sep, 17 | 44 | - |
| 30 Jun, 17 | 44 | - |
| 31 Mar, 17 | 44 | -13.73% |
| 31 Dec, 16 | 51 | 27.50% |
| 30 Sep, 16 | 40 | -2.44% |
| 30 Jun, 16 | 41 | 51.85% |
| 31 Mar, 16 | 27 | -43.75% |
| 31 Dec, 15 | 48 | -7.69% |
| 30 Sep, 15 | 52 | -13.33% |
| 30 Jun, 15 | 60 | -7.69% |
| 31 Mar, 15 | 65 | 30.00% |
| 31 Dec, 14 | 50 | 2.04% |
| 30 Sep, 14 | 49 | -18.33% |
| 30 Jun, 14 | 60 | 81.82% |
| 31 Mar, 14 | 33 | -38.89% |
| 31 Dec, 13 | 54 | - |
20 institutional shareholders have increased their position in KPTI stock as of 30 Jun 24 compared to 57 in the previous quarter (a -64.91% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 19 | -38.71% |
| 31 Mar, 24 | 31 | -24.39% |
| 31 Dec, 23 | 41 | 36.67% |
| 30 Sep, 23 | 30 | -28.57% |
| 30 Jun, 23 | 42 | 40.00% |
| 31 Mar, 23 | 30 | -25.00% |
| 31 Dec, 22 | 40 | -9.09% |
| 30 Sep, 22 | 44 | -21.43% |
| 30 Jun, 22 | 56 | 27.27% |
| 31 Mar, 22 | 44 | -4.35% |
| 31 Dec, 21 | 46 | 27.78% |
| 30 Sep, 21 | 36 | -33.33% |
| 30 Jun, 21 | 54 | -6.90% |
| 31 Mar, 21 | 58 | 38.10% |
| 31 Dec, 20 | 42 | -22.22% |
| 30 Sep, 20 | 54 | 45.95% |
| 30 Jun, 20 | 37 | -11.90% |
| 31 Mar, 20 | 42 | 7.69% |
| 31 Dec, 19 | 39 | 50.00% |
| 30 Sep, 19 | 26 | -18.75% |
| 30 Jun, 19 | 32 | 52.38% |
| 31 Mar, 19 | 21 | -38.24% |
| 31 Dec, 18 | 34 | -12.82% |
| 30 Sep, 18 | 39 | 62.50% |
| 30 Jun, 18 | 24 | 4.35% |
| 31 Mar, 18 | 23 | 4.55% |
| 31 Dec, 17 | 22 | 46.67% |
| 30 Sep, 17 | 15 | -25.00% |
| 30 Jun, 17 | 20 | -13.04% |
| 31 Mar, 17 | 23 | 35.29% |
| 31 Dec, 16 | 17 | -10.53% |
| 30 Sep, 16 | 19 | - |
| 30 Jun, 16 | 19 | -40.63% |
| 31 Mar, 16 | 32 | 45.45% |
| 31 Dec, 15 | 22 | -15.38% |
| 30 Sep, 15 | 26 | 52.94% |
| 30 Jun, 15 | 17 | 21.43% |
| 31 Mar, 15 | 14 | -30.00% |
| 31 Dec, 14 | 20 | 33.33% |
| 30 Sep, 14 | 15 | -16.67% |
| 30 Jun, 14 | 18 | -25.00% |
| 31 Mar, 14 | 24 | - |
| 31 Dec, 13 | - | - |
19 institutional shareholders have reduced their position in KPTI stock as of 30 Jun 24 compared to 31 in the previous quarter (a -38.71% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 57 | -52.50% | 25,574,412 | -65.80% | 22.15% | 0.52% | 20 | -64.91% | 19 | -38.71% |
| 31 Mar, 24 | 120 | -3.23% | 74,774,768 | 1.78% | 65.47% | 1.59% | 57 | 18.75% | 31 | -24.39% |
| 31 Dec, 23 | 124 | -1.59% | 73,464,527 | -4.85% | 64.22% | 1.41% | 48 | -14.29% | 41 | 36.67% |
| 30 Sep, 23 | 126 | -12.50% | 77,205,610 | -5.32% | 67.60% | 1.31% | 56 | -24.32% | 30 | -28.57% |
| 30 Jun, 23 | 144 | 5.88% | 81,541,549 | -6.87% | 71.85% | 1.21% | 74 | - | 42 | 40.00% |
| 31 Mar, 23 | 136 | -15.53% | 87,557,557 | -10.26% | 77.16% | 0.66% | 74 | -22.11% | 30 | -25.00% |
| 31 Dec, 22 | 161 | 5.92% | 97,570,382 | 46.34% | 108.49% | 1.57% | 95 | 21.79% | 40 | -9.09% |
| 30 Sep, 22 | 152 | -1.94% | 66,671,715 | -0.67% | 83.12% | 1.17% | 78 | 11.43% | 44 | -21.43% |
| 30 Jun, 22 | 155 | 5.44% | 67,120,164 | -1.71% | 84.27% | 1.09% | 70 | - | 56 | 27.27% |
| 31 Mar, 22 | 147 | -3.29% | 68,289,213 | 26.18% | 88.04% | 1.70% | 70 | -9.09% | 44 | -4.35% |
| 31 Dec, 21 | 152 | 7.04% | 54,118,861 | -5.47% | 71.95% | 1.25% | 77 | 11.59% | 46 | 27.78% |
| 30 Sep, 21 | 142 | -11.25% | 57,253,148 | -2.80% | 75.87% | 1.24% | 69 | -10.39% | 36 | -33.33% |
| 30 Jun, 21 | 160 | -9.09% | 58,904,876 | -2.06% | 78.34% | 1.20% | 77 | -7.23% | 54 | -6.90% |
| 31 Mar, 21 | 176 | -1.12% | 60,142,200 | -5.76% | 80.71% | 1.08% | 83 | -13.54% | 58 | 38.10% |
| 31 Dec, 20 | 178 | 6.59% | 63,820,587 | -2.00% | 86.56% | 1.10% | 96 | 14.29% | 42 | -22.22% |
| 30 Sep, 20 | 167 | 0.60% | 65,123,005 | -6.62% | 88.64% | 0.98% | 84 | -21.50% | 54 | 45.95% |
| 30 Jun, 20 | 166 | 9.93% | 69,739,080 | 2.55% | 95.22% | 0.94% | 107 | 27.38% | 37 | -11.90% |
| 31 Mar, 20 | 151 | -2.58% | 68,001,776 | 15.36% | 100.55% | 1.11% | 84 | -12.50% | 42 | 7.69% |
| 31 Dec, 19 | 155 | 37.17% | 58,945,053 | 0.81% | 95.14% | 1.07% | 96 | 47.69% | 39 | 50.00% |
| 30 Sep, 19 | 113 | 0.89% | 58,470,021 | 14.23% | 94.17% | 1.33% | 65 | 14.04% | 26 | -18.75% |
| 30 Jun, 19 | 112 | -2.61% | 51,186,747 | -0.11% | 84.01% | 1.18% | 57 | -9.52% | 32 | 52.38% |
| 31 Mar, 19 | 115 | -4.17% | 51,242,705 | -0.33% | 84.20% | 1.03% | 63 | -3.08% | 21 | -38.24% |
| 31 Dec, 18 | 120 | -4.76% | 51,413,229 | 18.72% | 90.55% | 1.77% | 65 | 30.00% | 34 | -12.82% |
| 30 Sep, 18 | 126 | 13.51% | 43,305,988 | -0.11% | 71.48% | 1.20% | 50 | -31.51% | 39 | 62.50% |
| 30 Jun, 18 | 111 | 15.63% | 43,354,460 | 40.34% | 77.30% | 1.99% | 73 | 40.38% | 24 | 4.35% |
| 31 Mar, 18 | 96 | 5.49% | 30,892,143 | -0.37% | 62.28% | 1.36% | 52 | - | 23 | 4.55% |
| 31 Dec, 17 | 91 | 12.35% | 31,007,685 | 7.88% | 67.56% | 1.82% | 52 | 18.18% | 22 | 46.67% |
| 30 Sep, 17 | 81 | -1.22% | 28,742,383 | 3.46% | 60.97% | 1.66% | 44 | - | 15 | -25.00% |
| 30 Jun, 17 | 82 | -5.75% | 27,781,253 | 3.48% | 60.62% | 1.48% | 44 | - | 20 | -13.04% |
| 31 Mar, 17 | 87 | -1.14% | 26,847,139 | 5.42% | 64.08% | 1.69% | 44 | -13.73% | 23 | 35.29% |
| 31 Dec, 16 | 88 | 7.32% | 25,467,502 | 9.86% | 61.55% | 1.55% | 51 | 27.50% | 17 | -10.53% |
| 30 Sep, 16 | 82 | 2.50% | 23,181,403 | 15.65% | 62.96% | 2.03% | 40 | -2.44% | 19 | - |
| 30 Jun, 16 | 80 | -2.44% | 20,044,979 | -5.30% | 55.75% | 1.60% | 41 | 51.85% | 19 | -40.63% |
| 31 Mar, 16 | 82 | -13.68% | 21,166,905 | -1.66% | 59.00% | 1.62% | 27 | -43.75% | 32 | 45.45% |
| 31 Dec, 15 | 95 | -4.04% | 21,524,797 | -8.80% | 60.43% | 1.38% | 48 | -7.69% | 22 | -15.38% |
| 30 Sep, 15 | 99 | 4.21% | 23,602,094 | 5.10% | 66.10% | 1.67% | 52 | -13.33% | 26 | 52.94% |
| 30 Jun, 15 | 95 | 5.56% | 22,456,409 | 7.99% | 62.91% | 1.81% | 60 | -7.69% | 17 | 21.43% |
| 31 Mar, 15 | 90 | 7.14% | 20,794,260 | 10.95% | 58.88% | 1.62% | 65 | 30.00% | 14 | -30.00% |
| 31 Dec, 14 | 84 | 15.07% | 18,742,490 | 11.44% | 60.20% | 2.26% | 50 | 2.04% | 20 | 33.33% |
| 30 Sep, 14 | 73 | -6.41% | 16,817,975 | 11.25% | 51.65% | 1.99% | 49 | -18.33% | 15 | -16.67% |
| 30 Jun, 14 | 78 | 30.00% | 15,117,626 | 49.76% | 50.97% | 4.38% | 60 | 81.82% | 18 | -25.00% |
| 31 Mar, 14 | 60 | 11.11% | 10,094,534 | 11.03% | 34.10% | 3.62% | 33 | -38.89% | 24 | - |
| 31 Dec, 13 | 54 | - | 9,091,630 | - | 30.71% | - | 54 | - | - | - |
Karyopharm Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Karyopharm Therapeutics's stock was made by Paulson Richard A. on Aug 08 2024, selling 3,608 shares at $0.93 per share (valued at $3.36K).
Karyopharm Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | 7 | 16 | 43.75% |
| Q1 2024 | 12 | 19 | 63.16% |
| Q4 2023 | - | 3 | - |
| Q3 2023 | 2 | 8 | 25.00% |
| Q2 2023 | 7 | 7 | 100.00% |
| Q1 2023 | 7 | 13 | 53.85% |
| Q4 2022 | - | 3 | - |
| Q3 2022 | 9 | 9 | 100.00% |
| Q2 2022 | 12 | 12 | 100.00% |
| Q1 2022 | 19 | 19 | 100.00% |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | - | 1 | - |
| Q2 2021 | 16 | 2 | 800.00% |
| Q1 2021 | 30 | 26 | 115.38% |
| Q4 2020 | 12 | 25 | 48.00% |
| Q3 2020 | 12 | 22 | 54.55% |
| Q2 2020 | 27 | 48 | 56.25% |
| Q1 2020 | 39 | 49 | 79.59% |
| Q4 2019 | 18 | 44 | 40.91% |
0 total buy trades, and 3 total sell trades (buy/sell ratio of 0.00%) were made by Karyopharm Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | - | 16 | - |
| Q1 2024 | - | 19 | - |
| Q4 2023 | - | 3 | - |
| Q3 2023 | 1 | 8 | 12.50% |
| Q2 2023 | - | 7 | - |
| Q1 2023 | - | 13 | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | - | 4 | - |
| Q2 2022 | - | 12 | - |
| Q1 2022 | - | 19 | - |
| Q4 2021 | - | 1 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 2 | 1 | 200.00% |
| Q1 2021 | - | 16 | - |
| Q4 2020 | - | 13 | - |
| Q3 2020 | 1 | 12 | 8.33% |
| Q2 2020 | - | 25 | - |
| Q1 2020 | - | 28 | - |
| Q4 2019 | - | 21 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Karyopharm Therapeutics's stocks.
Karyopharm Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| NUVB | Nuvation Bio Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| GOSS | Gossamer Bio, Inc. |
| MREO | Mereo BioPharma Group plc |
| HOOK | HOOKIPA Pharma Inc. |
| BLUE | bluebird bio, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| GBIO | Generation Bio Co. |
| REPL | Replimune Group, Inc. |
| RLYB | Rallybio Corporation |
| KRON | Kronos Bio, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| AGIO | Agios Pharmaceuticals, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| MRSN | Mersana Therapeutics, Inc. |
| NLTX | Neurogene Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
KPTI Ownership FAQ
Who Owns Karyopharm Therapeutics?
Karyopharm Therapeutics is owned by institutional shareholders (22.15%), insiders (6.07%), and public (71.78%). The largest institutional shareholder of Karyopharm Therapeutics is VANGUARD GROUP INC (6.63% of total shares) and the top mutual fund owner is SPARROW FUNDS (7.71% of total shares).
Who are the major institutional shareholders of Karyopharm Therapeutics?
Karyopharm Therapeutics's major institutional shareholders are VANGUARD GROUP INC, PALO ALTO INVESTORS LP, EVERSEPT PARTNERS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and BLACKROCK INC.. The top five shareholders own together 22.72% of the company's share outstanding.
How many Karyopharm Therapeutics shareholders are there?
As of Jun 2024, there are 57 institutional shareholders of Karyopharm Therapeutics.
What percentage of Karyopharm Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 7.65M shares of Karyopharm Therapeutics, representing 6.63% of the company's total shares outstanding, valued at $6.64M (as of Jun 2024).
What percentage of Karyopharm Therapeutics is owned by PALO ALTO INVESTORS LP?
As of Jun 2024, PALO ALTO INVESTORS LP holds 5.1M shares of Karyopharm Therapeutics (KPTI), compromising 4.42% of the company, valued at $4.43M.
What percentage of Karyopharm Therapeutics is owned by EVERSEPT PARTNERS, LP?
EVERSEPT PARTNERS, LP is the third largest holder of Karyopharm Therapeutics. The company owns 4.99M of the company's shares outstanding (worth $4.33M).